Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.
Cellular and Molecular Mechanisms Underpinning Macrophage Activation during Remyelination.
Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.
Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.
How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates.
Altered intracortical myelin staining in the dorsolateral prefrontal cortex in severe mental illness.
Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice.
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
g-Ratio weighted imaging of the human spinal cord in vivo.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Intra-rater reliability of the Modified Tardieu Scale in patients with multiple sclerosis.